|
|
News Breaks | | | | September 14, 2012 | | 08:04 EDT |  | LCI | Lannett receives FDA approval for Butalbital, Acetaminophen and Caffeine Tablets
Lannett Company has received approval from the FDA of its Abbreviated New Drug Application for Butalbital, Acetaminophen and Caffeine Tablets, USP, 50mg/325mg/40mg. According to IMS, for the year ended July 2012 total sales of Butalbital, Acetaminophen and Caffeine Tablets at Average Wholesale Price were approximately $30M, of which about $15M was for the brand version, Fioricet®. The company expects to commence shipping the product next month. | |
|
News For LCI From The Last 14 Days Check below for free stories on LCI the last two weeks. |
|
|
| May 8, 2013 | | 16:21 EDT |  | LCI | Lannett raises FY13 EPS outlook to $147M-$149M from $140M-$142M
 Subscribe for More Information | | | 16:20 EDT | | LCI | Lannett reports Q3 EPS 14c, consensus 3c
Subscribe for More Information | |
|
|
|
|
|
|
